+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease



Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease



Journal of Investigative Dermatology 96(3): 47s



The typical bone marrow lesions seen in adults with systemic mast cell disease (SMCD) are foci of spindle-shaped mast cells in a fibrotic matrix and are found in up to 90% of adults with SMCD. Lymphocytes and eosinophils frequently are admixed with the mast cells, forming the classic MEL lesion. The mast cell lesions can be found in perivascular, peritrabecular or intertrabecular locations and may on occasion completely replace intratrabecular regions of the marrow. In contrast, the mast cell lesions found in children with cutaneous mast cell disorders are uniformly small and subtle and are most frequently located perivascularly. Lymphocytes, eosinophils, and early myeloid elements may be associated with these lesions. Of perhaps greater specificity for SMCD is the finding of confluent clusters of mast cells on the marrow aspirates; such clusters are noted in up to 30% of patients with SMCD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040260861

Download citation: RISBibTeXText

PMID: 2002263

DOI: 10.1111/1523-1747.ep12469034


Related references

Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease. Journal of Investigative Dermatology 96(3): 52s, 1991

The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD). Blood 116(5): 850-851, 2010

Bone marrow pathology in 5 cases of systemic mastocytosis. Pseudomyelomatous forms with dysglobulinemia and benign polyclonal bone marrow plasmacytosis. Hamazaki-Wesenberg bodies associated with mast cell granulomas. Archives d'Anatomie et de Cytologie Pathologiques 31(1): 11-18, 1983

Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. American Journal of Clinical Pathology 124(4): 560-568, 2005

Delineation of Patterns of Bone Marrow Mast Cell Infiltration in Systemic Mastocytosis: Value of CD25, Correlation With Subvariants of the Disease, and Separation From Mast Cell Hyperplasia. Yearbook of Pathology and Laboratory Medicine 2007: 282-283, 2007

Delineation of Patterns of Bone Marrow Mast Cell Infiltration in Systemic Mastocytosis : Value of Cd25, Correlation With Subvariants of the Disease, and Separation From Mast Cell Hyperplasia. American Journal of Clinical Pathology 124(4): 560-568, 2005

The faces of mast cell disease: bone marrow infiltrates in 3 patients with systemic mastocytosis. Annals of Diagnostic Pathology 9(2): 81-85, 2005

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108(7): 2366-2372, 2006

Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient. Journal of Dermatology 41(8): 761-763, 2014

Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count. American Journal of Clinical Pathology 139(3): 404-406, 2013

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis. International Journal of Molecular Sciences 20(3):, 2019

Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: An example of a smoldering case?. Leukemia Research 25(7): 635-638, 2001

Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis. Haematologica 89(12): 1525-1527, 2004

Demonstration of stem cell factor associated with mast cells in the bone marrow of patients with systemic indolent mastocytosis. Blood 94(10 Suppl. 1 Part 2): 37b, 1999

Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis. Leukemia and Lymphoma 54(9): 1959-1964, 2013